Helmut Kranzbühler
Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
Ferraro D, Hermanns T, Kaufmann P, Omlin A, Kranzbühler H, Gablinger R, Müller A, Müller J, Eberli D, Muehlematter U, Garcia Schüler H, Burger I. Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer. Eur J Nucl Med Mol Imaging 2019
04.12.2019Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
04.12.2019Eur J Nucl Med Mol Imaging 2019
Ferraro Daniela A, Hermanns Thomas, Kaufmann Philipp A, Omlin Aurelius, Kranzbühler Helmut, Gablinger Roger, Müller Alexander, Müller Julian, Eberli Daniel, Muehlematter Urs J, Garcia Schüler Helena I, Burger Irene A
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Ghadjar P, Kranzbühler H, Najafi Y, Ost P, Azinwi N, Reuter C, Bodis S, Kaouthar K, Budach V, Aebersold D, Thalmann G, Sumila M, Biaggi-Rudolf C, Stalder L, Hayoz S, Genitsch V, Zwahlen D, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A, Putora P, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
19.01.2017Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
19.01.2017BJU Int 2017; 120:E45-E51
Ghadjar Pirus, Kranzbühler Helmut, Najafi Yousef, Ost Piet, Azinwi Ngwa C, Reuter Christiane, Bodis Stephan, Kaouthar Khanfir, Budach Volker, Aebersold Daniel M, Thalmann George N, Sumila Marcin, Biaggi-Rudolf Christine, Stalder Lukas, Hayoz Stefanie, Genitsch Vera, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Guckenberger Matthias, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Sassowsky M, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold D, Plasswilm L, Azinwi N, Zwahlen D, Gut P, Hölscher T, Hildebrandt G, Müller A, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Ghadjar P. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 2013; 87:534-41.
22.08.2013Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
22.08.2013Int J Radiat Oncol Biol Phys 2013; 87:534-41
Sassowsky Manfred, Takacs Istvan, Reuter Christiane, Sumila Marcin, Manser Peter, Ost Piet, Böhmer Dirk, Pilop Christiane, Aebersold Daniel M, Plasswilm Ludwig, Azinwi Ngwa C, Zwahlen Daniel R, Gut Philipp, Hölscher Tobias, Hildebrandt Guido, Müller Arndt-Christian, Najafi Yousef, Kohler Götz, Kranzbühler Helmut, Guckenberger Matthias, Ghadjar Pirus